In vitro cytotoxicity assay to screen compounds for apoptosis-inducing potential on lymphocytes and neutrophils.
- 1 January 2002
- journal article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 27 (3) , 191-203
- https://doi.org/10.2131/jts.27.191
Abstract
In vitro cytotoxicity assay to screen compounds for apoptosis-inducing potential on lymphocytes and neutrophils was investigated. Mouse, rat, dog, and human whole blood were incubated for 4 and 6 hr with actinomycin D, camptothecin, cortisone acetate, cycloheximide, doxorubicin, etoposide, 5-FU, mitomycin C and puromycin. Apoptotic lymphocytes and neutrophils were counted. All test compounds induced in vitro apoptosis of lymphocytes and/or neutrophils, but there were different potencies among the test compounds and there were also species differences in susceptibility. To investigate the in vivo effects of etoposide and cycloheximide which induced apoptosis of rat lymphocytes and that of rat lymphocytes and neutrophils, respectively, in in vitro assay, rats were intravenously administered either etoposide at 12.5, 25 or 50 mg/kg or cycloheximide at 1.25, 2.5 or 5 mg/kg. Etoposide caused decreases of circulating lymphocytes at 3 hr after administration in a dose-dependent manner, -16, -25 and -51%. Although cycloheximide caused neither decreased lymphocyte nor neutrophil counts, apoptosis in 30% of neutrophils was observed in rats receiving 5 mg/kg at 3 hr after administration. Etoposide at 50 mg/kg and cycloheximide at 5 mg/kg caused lymphocyte apoptosis in the spleen, thymus, mesenteric lymph nodes, bone marrow, and Peyer's patch from 1 to 6 hr after administration, with the maximum changes at 3 hr. In addition to apoptosis of these organs, cycloheximide at 5 mg/kg caused apoptosis of polymorphonuclear cells in the lamina propria of the small intestine. Therefore, it was found that the changes seen in the in vivo experiments considerably reflected the changes seen in the in vitro experiments. From these results, apoptosis is probably one of the major mechanisms for leukocyte toxicity induced by cytotoxic compounds, and the in vitro assay to screen compounds for acute apoptosis-inducing potential on lymphocytes and neutrophils would be useful as a primary screening method for animal toxicity studies. It may also be useful for risk assessments in advance of clinical trials.Keywords
This publication has 34 references indexed in Scilit:
- Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cellsCell Death & Differentiation, 2002
- Apoptotic Human Lymphocytes Have Diminished CD4 and CD8 Receptor ExpressionCellular Immunology, 1999
- Contribution of Gene-Specific Lesions, DNA-Replication-Associated Damage, and Subsequent Transcriptional Inhibition in Topoisomerase Inhibitor-Mediated Apoptosis in Lymphoma CellsExperimental Cell Research, 1998
- Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosisClinical and Experimental Immunology, 1997
- Apoptosis-mediated immunotoxicity of polychlorinated biphenyls (PCBs) murine splenocytesToxicology Letters, 1997
- Cellular and biochemical requirements for thymocyte negative selectionSeminars in Immunology, 1996
- Simultaneous evaluation of dexamethasone-induced apoptosis and micronuclei in rat primary spleen cell culturesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1995
- Apoptosis and Macrophage‐Mediated Cell Deletion in the Regulation of B Lymphopoiesis in Mouse Bone MarrowImmunological Reviews, 1994
- Programmed cell death of the normal human neutrophil: An in vitro model of senescenceMicroscopy Research and Technique, 1994
- Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosisEuropean Journal of Immunology, 1991